MCRP 3-40A.3 governs multiservice tactics, techniques, and procedures for treatment of biological warfare agent casualties.
View MCRP 3-40A.3 on armypubs.army.mil
MCRP 3-40A.3 covers biological warfare agents, emerging infectious diseases, casualty recognition, and identification technologies. It includes requirements for managing biological casualties, collecting specimens, and identifying agents through laboratory networks.
Follow these ten steps in the management of biological casualties on the battlefield— Maintain an index of suspicion. Protect yourself. Assess the patient. Decontaminate as appropriate. Establish a diagnosis. Render prompt treatment. Practice good infection control. Alert the proper authorities. Assist in the epidemiologic investigation and manage the psychological consequences. Maintain proficiency and spread the word.
Of these, anthrax is the most likely BW threat that troops will encounter in an area of operations. (paragraph 3-2)
Humans can contract anthrax from inhalation of aerosolized spores released during a BW attack. (paragraph 3-5)
Medical personnel have the primary responsibility for collecting and testing clinical specimens (for example, human blood, tissue, urine, and sputum) for BW agents. (paragraph 6-25)
The Laboratory Response Network is an early warning network to detect the covert use of pathogenic agents. (paragraph 6-24)